Vimarsana
Biggest News Aggregation in the World

Page 3 - Associate Editors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Associate Editors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Associate Editors Today - Breaking & Trending Today

'A Catastrophic Mistake': Upheaval at Philosophy Journal Points to Publishing's Conflicting Interests - Vimarsana News

'A Catastrophic Mistake': Upheaval at Philosophy Journal Points to Publishing's Conflicting Interests

Wiley’s removal of the longtime editor of a prominent political-philosophy journal has spurred charges that the company is trying to maximize production, not quality.

The multiple uses of peer review: an interview with Marcel LaFlamme - Vimarsana News

The multiple uses of peer review: an interview with Marcel LaFlamme

Thoughts on how to advance open science beyond the published article

Source: plos.org
Editorials – Week 1 – The Oxford Student - Vimarsana News

Editorials – Week 1 – The Oxford Student

The Oxford Student HT23 Editors write their first editorials of the term, looking back at their experience on the paper so far.

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial | Critical Care Medicine | JAMA - Vimarsana News

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial | Critical Care Medicine | JAMA

This secondary analysis of an ongoing adaptive platform trial examines the effect of multiple interventions for critically ill adults with COVID-19 on longer-te

Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors - Vimarsana News

Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors

Researchers from City of Hope find only 30% of people with neuroendocrine tumors consider living longer to be their single top priority; 70% said addressing and overcoming pain, fatigue, or lack-of-function was more important than just prolonging life. JNCCN announces five new Associate Editors from Duke Cancer Institute, City of Hope, Mayo Clinic Cancer Center, University of Michigan...